
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA updates Elevidys labeling with boxed warning and revised indication following reports of fatal liver injury
2
Valeria Cohran, MD, highlights specialist-pediatrician collaboration when treating short bowel syndrome-associated intestinal failure
3
Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis
4
Valeria Cohran, MD, discusses teduglutide response in children with SBS-IF
5












